Additional Data on Sputnik V Vaccine's Efficacy to Be Published in Top Journal - RDIF

Sputnik, 02.12.2020

MOSCOW, December 2 (Sputnik) - Additional data on the efficacy of Russia's Sputnik V vaccine against the coronavirus will be published in a top peer-reviewed magazine, CEO of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said Wednesday.

"We showed clearly efficacy [of the Sputnik V vaccine] is about 90 percent and additional data will be also published in one of the top peer-reviewed magazines," Dmitriev said at a presentation of the vaccine at the UN.